Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Huber Presents the 4 Aces of Temperature Control!

Published: Thursday, August 15, 2013
Last Updated: Thursday, August 15, 2013
Bookmark and Share
Huber has a winning hand with a suite of very compact, high efficiency and low-cost products.

Huber offers temperature control systems to match the demands of almost any application requirement. Ranging from the Unistat Hybrid, which can be integrated into centralised systems for large volume reactors, to small chillers, immersion and circulation thermostats. Despite their size, these units are real all-rounders, offering incredible power with small foot prints and environmentally friendly refrigeration – making them truly product aces.

The Petite Fleur with a working temperature of -40 °C to +200 °C is the smallest, hydraulically sealed dynamic temperature control system in the Unistat series and ideally suited to control small research reactors.

Since its launch, the Petite Fleur has become a bestseller in the Huber product range. The Petite Fleur has unique thermodynamic properties and in comparison to other machines, the Petite Fleur is unrivaled when it comes to responsive temperature control.

Huber Ministats are the smallest cooling thermostats in the world! Despite their size they have enough power to thermoregulate photometers, refractometers, viscosimeters, distillation apparatus, reactor vessels and mini plants. Their compact form allows them to be placed in areas where space is at a premium, for example laboratory extraction hoods. Ministats are available in 3 models with a temperature range from -45 °C to +200 °C and cooling capacities of 600 watts. They can be used to control externally closed applications or alternatively objects can be thermoregulated directly within the bath.

The compact Minichiller is designed as a space saving tower and with a footprint of just 225 x 360 mm it takes up less bench space than many laptops. With a temperature range of -20 °C to +40 °C and cooling capacity of 300 watts at 15 °C, Minichillers are ideal for cooling reaction blocks, vapour traps, vacuum pump condensers, rotary evaporators or heat exchangers, supplying predictable and correct pressure, flow and temperature to applications resulting in tangible process efficiencies. It ensures constant temperatures and highly efficient condensation of flow through vapours. The Minichiller is designed for continuous operation in ambient temperatures up to +40 °C.

The Compatible Control models and the simpler MPC circulators are modern classics. Both product lines represent classically constructed laboratory circulators with open baths. The pump, control sensor, heater and evaporator are all located at the back part of the bath. This allows the use of both, optional calibration inserts for high precision calibration and also displacement inserts for increasing system temperature dynamics. Baths and circulators for heating applications up to +300 °C are available, as well as models for heating and cooling applications from -90 °C to +200 °C.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!